Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
boston blog main
2
×
cancer
2
×
clinical trials
general atlantic
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
startups
2
×
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
biotech
bluerock therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
cerovene
community oncology alliance
covid-19
crispr
cvs health
deals
deerfield management
detroit blog main
detroit top stories
dna sequencing
drew pardoll
durvalumab
editas medicine
What
medicines
2
×
acquisitions
aim
announced
bio
boost
cancer
ceo
change
collabs
community
covid
daniel
deal
diagnostics
docs
flatiron
gilead
gilead’s
help
helped
immunotherapy
introduce
ipo
month
new
number
oneoncology
o’day
past
plans
roundup
sciences
targeted
technologies
transformative
years
Language
unset
Current search:
medicines
×
cancer
×
" boston blog main "
×
startups
×
" general atlantic "
×
photo
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care